Nevertheless, with a P -value of 0.54 in our currently analysed patient cohort with PC treated with contemporary chemotherapy protocols a trend towards significance in tumour-related survival benefit is recognisable, that may become provable with rising numbers of patients in this group.
← all excerpts
Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades.
1
—
—